INFECCIÓN RESPIRATORIA Y RESISTENCIA ANTIMICROBIANA
Hospital de Gran Canaria Dr. Negrin
Las Palmas de Gran Canaria, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Gran Canaria Dr. Negrin (19)
2022
-
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients
Orphanet Journal of Rare Diseases, Vol. 17, Núm. 1
-
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 21
2021
-
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
Science immunology, Vol. 6, Núm. 62
-
Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia
ERJ Open Research, Vol. 7, Núm. 1
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2018
-
Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study
Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482
2017
-
Improved survival among ICU-hospitalized patients with community-acquired pneumonia by unidentified organisms: a multicenter case–control study
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 1, pp. 123-130
-
Infection control, genetic assessment of drug resistance and drug susceptibility testing in the current management of multidrug/extensively-resistant tuberculosis (M/XDR-TB) in Europe: A tuberculosis network European Trialsgroup (TBNET) study
Respiratory Medicine, Vol. 132, pp. 68-75
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
-
Procalcitonin (PCT) levels for ruling-out bacterial coinfection in ICU patients with influenza: A CHAID decision-tree analysis
Journal of Infection, Vol. 72, Núm. 2, pp. 143-151
2015
-
Pneumococcal pneumonia coinfection in critically ill patients with influenza a (H1n1) primary viral pneumonia
Intensive Care Medicine Experimental
2013
-
Community-acquired Legionella Pneumonia in the intensive care unit: Impact on survival of combined antibiotic therapy
Medicina Intensiva, Vol. 37, Núm. 5, pp. 320-326
-
Viral infections of the central nervous system in Spain: A prospective study
Journal of Medical Virology, Vol. 85, Núm. 3, pp. 554-562
2012
-
Recomendaciones del Grupo de Trabajo Enfermedades Infecciosas (GTEI) de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC) y el Grupo de Estudio de Infecciones en el Paciente Crítico (GEIPC) de la Sociedad Espanola de Enfermedades Infecciosas y Microbiología clinica (SEIMC) para el diagnóstico y tratamiento de la gripe A/H1N1
Medicina Intensiva, Vol. 36, Núm. 2, pp. 103-137
2011
-
Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus
Chest, Vol. 139, Núm. 3, pp. 555-562
-
Impact of obesity in patients infected with 2009 influenza A(H1N1)
Chest, Vol. 139, Núm. 2, pp. 382-386
-
Severe pandemic (H1N1)v influenza A infection: Report on the first deaths in Spain
Respirology, Vol. 16, Núm. 1, pp. 78-85
2000
-
Micobacterias ambientales en España: Aislamientos en el período 1976-1996
Medicina Clinica, Vol. 115, Núm. 17, pp. 663-670